메뉴 건너뛰기




Volumn 184, Issue 1, 2003, Pages 9-13

Long-term L-DOPA therapy: Challenges to our understanding and for the care of people with Parkinson's disease

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE; LEVODOPA;

EID: 0345257779     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00304-2     Document Type: Note
Times cited : (15)

References (61)
  • 1
    • 0035353725 scopus 로고    scopus 로고
    • Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
    • Ahlskog J.E., Muenter M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov. Disord. 16:2001;448-458.
    • (2001) Mov. Disord. , vol.16 , pp. 448-458
    • Ahlskog, J.E.1    Muenter, M.D.2
  • 3
    • 0015745743 scopus 로고
    • Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological, and neurochemical correlations
    • Bernheimer H., Birkmayer W., Hornykiewicz O. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological, and neurochemical correlations. J. Neurol. Sci. 20:1973;415-455.
    • (1973) J. Neurol. Sci. , vol.20 , pp. 415-455
    • Bernheimer, H.1    Birkmayer, W.2    Hornykiewicz, O.3
  • 4
    • 73049129373 scopus 로고
    • The effect of L-3,4-dihydroxyphenylalanine (DOPA) on akinesia in Parkinson's syndrome
    • Birkmeyer W., Hornykiewicz O. The effect of L-3,4-dihydroxyphenylalanine (DOPA) on akinesia in Parkinson's syndrome. Wein. Klin. Wochenschr. 73:1961;787-788.
    • (1961) Wein. Klin. Wochenschr. , vol.73 , pp. 787-788
    • Birkmeyer, W.1    Hornykiewicz, O.2
  • 5
    • 0028238804 scopus 로고
    • Wearing-off fluctuations in Parkinson's disease: Contributions of postsynaptic mechanisms
    • Bravi D., Mouradian M.D., Roberts J.W., Davis T.L., Sohn Y.H., Chase T.N. Wearing-off fluctuations in Parkinson's disease contributions of postsynaptic mechanisms. Ann. Neurol. 36:1994;27-31.
    • (1994) Ann. Neurol. , vol.36 , pp. 27-31
    • Bravi, D.1    Mouradian, M.D.2    Roberts, J.W.3    Davis, T.L.4    Sohn, Y.H.5    Chase, T.N.6
  • 6
    • 0032889986 scopus 로고    scopus 로고
    • Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: Studies on medial forebrain bundle and striatal lesions
    • Chang J.W., Wachtel S.R., Young D., Kang U.J. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease Studies on medial forebrain bundle and striatal lesions. Neuroscience. 88:1999;617-628.
    • (1999) Neuroscience , vol.88 , pp. 617-628
    • Chang, J.W.1    Wachtel, S.R.2    Young, D.3    Kang, U.J.4
  • 7
    • 0031954732 scopus 로고    scopus 로고
    • Levodopa therapy: Consequences of the nonphysiologic replacement of dopamine
    • Chase T.N. Levodopa therapy consequences of the nonphysiologic replacement of dopamine. Neurology. 50:1998;S17-S25.
    • (1998) Neurology , vol.50
    • Chase, T.N.1
  • 8
    • 0029920096 scopus 로고    scopus 로고
    • Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: Implications for the pathogenesis of the on-off phenomenon
    • Colosimo C., Merello M., Hughes A.J., Sieradzan K., Lees A.J. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease implications for the pathogenesis of the on-off phenomenon. J. Neurol. Neurosurg. Psychiatry. 61:1996;634-637.
    • (1996) J. Neurol. Neurosurg. Psychiatry , vol.61 , pp. 634-637
    • Colosimo, C.1    Merello, M.2    Hughes, A.J.3    Sieradzan, K.4    Lees, A.J.5
  • 9
    • 0026765992 scopus 로고
    • Kinetic-dynamic relationship of oral levodopa: Possible biphasic response after sequential doses in Parkinson's disease
    • Contin M., Riva R., Martinelli P., Baruzzi A. Kinetic-dynamic relationship of oral levodopa possible biphasic response after sequential doses in Parkinson's disease. Mov. Disord. 7:1992;244-248.
    • (1992) Mov. Disord. , vol.7 , pp. 244-248
    • Contin, M.1    Riva, R.2    Martinelli, P.3    Baruzzi, A.4
  • 10
    • 0027477017 scopus 로고
    • Pharmacodynamic modeling of oral levodopa: Clinical application in Parkinson's disease
    • Contin M., Riva R., Martinelli P., Cortelli P., Albani F., Baruzzi A. Pharmacodynamic modeling of oral levodopa clinical application in Parkinson's disease. Neurology. 43:1993;367-371.
    • (1993) Neurology , vol.43 , pp. 367-371
    • Contin, M.1    Riva, R.2    Martinelli, P.3    Cortelli, P.4    Albani, F.5    Baruzzi, A.6
  • 11
    • 0027930341 scopus 로고
    • Longitudinal monitoring of the levodopa concentration-effect relationship in Parkinson's disease
    • Contin M., Riva R., Martinelli P., Cortelli P., Albani F., Baruzzi A. Longitudinal monitoring of the levodopa concentration-effect relationship in Parkinson's disease. Neurology. 44:1994;1287-1292.
    • (1994) Neurology , vol.44 , pp. 1287-1292
    • Contin, M.1    Riva, R.2    Martinelli, P.3    Cortelli, P.4    Albani, F.5    Baruzzi, A.6
  • 12
    • 0014673226 scopus 로고
    • Modification of parkinsonism: Chronic treatment with L-dopa
    • Cotzias G.C., Papavasiliou P.S., Gellene R. Modification of parkinsonism chronic treatment with L-dopa. N. Engl. J. Med. 280:1969;337-345.
    • (1969) N. Engl. J. Med. , vol.280 , pp. 337-345
    • Cotzias, G.C.1    Papavasiliou, P.S.2    Gellene, R.3
  • 17
    • 0023762236 scopus 로고
    • Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part I
    • Fabbrini G., Mouradian M.M., Juncos J.L., Schlegel J., Mohr E., Chase T.N. Motor fluctuations in Parkinson's disease central pathophysiological mechanisms, Part I. Ann. Neurol. 24:1988;366-371.
    • (1988) Ann. Neurol. , vol.24 , pp. 366-371
    • Fabbrini, G.1    Mouradian, M.M.2    Juncos, J.L.3    Schlegel, J.4    Mohr, E.5    Chase, T.N.6
  • 18
    • 0031715932 scopus 로고    scopus 로고
    • Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease
    • Harder S., Baas H. Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease. Clin. Pharmacol. Ther. 64:1998;183-191.
    • (1998) Clin. Pharmacol. Ther. , vol.64 , pp. 183-191
    • Harder, S.1    Baas, H.2
  • 19
    • 0021142576 scopus 로고
    • On-off fluctuations in Parkinson's disease: A clinical and neuropharmacological study
    • Hardie R.J., Lees A.J., Stern G.M. On-off fluctuations in Parkinson's disease a clinical and neuropharmacological study. Brain. 107:1984;487-506.
    • (1984) Brain , vol.107 , pp. 487-506
    • Hardie, R.J.1    Lees, A.J.2    Stern, G.M.3
  • 20
    • 0036764810 scopus 로고    scopus 로고
    • Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease
    • Hauser R.A., Holford N.H. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease. Mov Disord. 17:2002;961-968.
    • (2002) Mov Disord. , vol.17 , pp. 961-968
    • Hauser, R.A.1    Holford, N.H.2
  • 21
    • 0016268257 scopus 로고
    • The mechanisms of action of L-Dopa in Parkinson's disease
    • Hornykiewicz O. The mechanisms of action of L-Dopa in Parkinson's disease. Life. Sci. 15:1974;1249-1259.
    • (1974) Life. Sci. , vol.15 , pp. 1249-1259
    • Hornykiewicz, O.1
  • 23
    • 0036460942 scopus 로고    scopus 로고
    • Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two-year, prospective follow-up
    • Kanovsky P., Kubova D., Bares M., Hortova H., Streitova H., Rektor I., Znojil V. Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine results of a two-year, prospective follow-up. Mov. Disord. 17:2002;188-191.
    • (2002) Mov. Disord. , vol.17 , pp. 188-191
    • Kanovsky, P.1    Kubova, D.2    Bares, M.3    Hortova, H.4    Streitova, H.5    Rektor, I.6    Znojil, V.7
  • 25
    • 0002664244 scopus 로고
    • Psychomotor stimulant-induced sensitization: Behavior and neurochemical correlates
    • P.W. Kalivas, & C.D. Barnes. Caldwell, NJ: Telford Press
    • Kuczenski R., Segal D.S. Psychomotor stimulant-induced sensitization behavior and neurochemical correlates. Kalivas P.W., Barnes C.D. Sensitization in the Nervous System. 1988;177-205 Telford Press, Caldwell, NJ.
    • (1988) Sensitization in the Nervous System , pp. 177-205
    • Kuczenski, R.1    Segal, D.S.2
  • 27
    • 0345227297 scopus 로고    scopus 로고
    • The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations
    • Lee, E.A., Lee, W.Y., Kim, Y.S., Kang, U.J., 2003. The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations. Exp. Neurol. 184, 304-312.
    • (2003) Exp. Neurol. , vol.184 , pp. 304-312
    • Lee, E.A.1    Lee, W.Y.2    Kim, Y.S.3    Kang, U.J.4
  • 28
    • 0026551551 scopus 로고
    • Levodopa-induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification
    • Luquin M.R., Scipioni O., Vaamonde J., Gershanik O., Obeso J.A. Levodopa-induced dyskinesias in Parkinson's disease clinical and pharmacological classification. Mov. Disord. 7:1992;117-124.
    • (1992) Mov. Disord. , vol.7 , pp. 117-124
    • Luquin, M.R.1    Scipioni, O.2    Vaamonde, J.3    Gershanik, O.4    Obeso, J.A.5
  • 29
    • 0033616439 scopus 로고    scopus 로고
    • Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum
    • Maeda T., Kannari K., Suda T., Matsunga M. Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum. Brain. Res. 817:1999;185-191.
    • (1999) Brain. Res. , vol.817 , pp. 185-191
    • Maeda, T.1    Kannari, K.2    Suda, T.3    Matsunga, M.4
  • 30
    • 0036869028 scopus 로고    scopus 로고
    • Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients
    • Manson A.J., Turner K., Lees A.J. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease long-term follow-up study of 64 patients. Mov. Disord. 17:2002;1235-1241.
    • (2002) Mov. Disord. , vol.17 , pp. 1235-1241
    • Manson, A.J.1    Turner, K.2    Lees, A.J.3
  • 31
    • 0017275668 scopus 로고
    • "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy
    • Marsden C.D., Parkes J.D. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet. 1:1976;292-296.
    • (1976) Lancet , vol.1 , pp. 292-296
    • Marsden, C.D.1    Parkes, J.D.2
  • 32
    • 0026472109 scopus 로고
    • Begining-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease
    • Merello M., Lees A.J. Begining-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 55:1992;1024-1026.
    • (1992) J. Neurol. Neurosurg. Psychiatry , vol.55 , pp. 1024-1026
    • Merello, M.1    Lees, A.J.2
  • 36
    • 0017468670 scopus 로고
    • Patterns of dystonia ("I-D-I" and "D-I-D") in response to L-Dopa therapy for Parkinson's disease
    • Muenter M.D., Sharpless N.S., Tyce G.M., Darley F.L. Patterns of dystonia ("I-D-I" and "D-I-D") in response to L-Dopa therapy for Parkinson's disease. Mayo Clin. Proc. 52:1977;163-174.
    • (1977) Mayo Clin. Proc. , vol.52 , pp. 163-174
    • Muenter, M.D.1    Sharpless, N.S.2    Tyce, G.M.3    Darley, F.L.4
  • 37
    • 0015043830 scopus 로고
    • L-DOPA therapy of Parkinson's disease: Plasma L-DOPA concentration, therapeutic response, and side effects
    • Muenter M.D., Tyce G.M. L-DOPA therapy of Parkinson's disease plasma L-DOPA concentration, therapeutic response, and side effects. Mayo Clin. Proc. 46:1971;231-239.
    • (1971) Mayo Clin. Proc. , vol.46 , pp. 231-239
    • Muenter, M.D.1    Tyce, G.M.2
  • 38
    • 0033962207 scopus 로고    scopus 로고
    • Apomorphine can sustain the long-duration response to L-DOPA in fluctuating PD
    • Nutt J.G., Carter J.H. Apomorphine can sustain the long-duration response to L-DOPA in fluctuating PD. Neurology. 54:2000;247-250.
    • (2000) Neurology , vol.54 , pp. 247-250
    • Nutt, J.G.1    Carter, J.H.2
  • 39
    • 0036264465 scopus 로고    scopus 로고
    • Evolution of the response to levodopa during the first 4 years of therapy
    • Nutt J.G., Carter J.H., Lea E.S., Sexton G.J. Evolution of the response to levodopa during the first 4 years of therapy. Ann. Neurol. 51:2002;686-693.
    • (2002) Ann. Neurol. , vol.51 , pp. 686-693
    • Nutt, J.G.1    Carter, J.H.2    Lea, E.S.3    Sexton, G.J.4
  • 40
    • 0030799456 scopus 로고    scopus 로고
    • Short- and long-duration responses to levodopa during the first year of levodopa therapy
    • Nutt J.G., Carter J.H., Van Houten L., Woodward W.R. Short- and long-duration responses to levodopa during the first year of levodopa therapy. Ann. Neurol. 42:1997;349-355.
    • (1997) Ann. Neurol. , vol.42 , pp. 349-355
    • Nutt, J.G.1    Carter, J.H.2    Van Houten, L.3    Woodward, W.R.4
  • 41
    • 0023729233 scopus 로고
    • Does an inhibitory action of levodopa contribute to motor fluctuations?
    • Nutt J.G., Gancher S.T., Woodward W.R. Does an inhibitory action of levodopa contribute to motor fluctuations? Neurology. 38:1988;1553-1557.
    • (1988) Neurology , vol.38 , pp. 1553-1557
    • Nutt, J.G.1    Gancher, S.T.2    Woodward, W.R.3
  • 42
    • 0029883235 scopus 로고    scopus 로고
    • The response to levodopa in Parkinson's disease: Imposing pharmacological law and order
    • Nutt J.G., Holford N.H.G. The response to levodopa in Parkinson's disease imposing pharmacological law and order. Ann. Neurol. 39:1996;561-573.
    • (1996) Ann. Neurol. , vol.39 , pp. 561-573
    • Nutt, J.G.1    Holford, N.H.G.2
  • 44
    • 0022443805 scopus 로고
    • Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients
    • Nutt J.G., Woodward W.R. Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients. Neurology. 36:1986;739-744.
    • (1986) Neurology , vol.36 , pp. 739-744
    • Nutt, J.G.1    Woodward, W.R.2
  • 45
    • 0026480977 scopus 로고
    • Effect of long-term therapy on the pharmacodynamics of levodopa: Relation to on-off phenomenon
    • Nutt J.G., Woodward W.R., Carter J.H., Gancher S.T. Effect of long-term therapy on the pharmacodynamics of levodopa relation to on-off phenomenon. Arch. Neurol. 49:1992;1123-1130.
    • (1992) Arch. Neurol. , vol.49 , pp. 1123-1130
    • Nutt, J.G.1    Woodward, W.R.2    Carter, J.H.3    Gancher, S.T.4
  • 46
    • 0021674129 scopus 로고
    • Dopamine metabolism in the central nervous system after discontinuation of L-dopa therapy in patients with Parkinsons disease
    • Ogasahara S., Nishikawa Y., Takahashi M., Wada K., Nakamura Y., Yorifuji S., Tarul S. Dopamine metabolism in the central nervous system after discontinuation of L-dopa therapy in patients with Parkinsons disease. J. Neurol. Sci. 66:1984;151-163.
    • (1984) J. Neurol. Sci. , vol.66 , pp. 151-163
    • Ogasahara, S.1    Nishikawa, Y.2    Takahashi, M.3    Wada, K.4    Nakamura, Y.5    Yorifuji, S.6    Tarul, S.7
  • 47
    • 0034069554 scopus 로고    scopus 로고
    • Preventing levodopa-induced dyskinesias
    • Olanow C.W., Obeso J.A. Preventing levodopa-induced dyskinesias. Ann. Neurol. 47:2000;S167-S176.
    • (2000) Ann. Neurol. , vol.47
    • Olanow, C.W.1    Obeso, J.A.2
  • 48
    • 0029064091 scopus 로고
    • Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
    • Olsson M., Nikkah G., Bentlage C., Bjorklund A. Forelimb akinesia in the rat Parkinson model differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15:1995;3863-3875.
    • (1995) J. Neurosci. , vol.15 , pp. 3863-3875
    • Olsson, M.1    Nikkah, G.2    Bentlage, C.3    Bjorklund, A.4
  • 49
    • 0022446286 scopus 로고
    • L-Dopa: How it may exacerbate parkinsonian symptoms
    • Paalzow G.H.M., Paalzow L.K. L-Dopa how it may exacerbate parkinsonian symptoms. Trends Pharmacol. Sci. 9:1986;15-19.
    • (1986) Trends Pharmacol. Sci. , vol.9 , pp. 15-19
    • Paalzow, G.H.M.1    Paalzow, L.K.2
  • 50
    • 0028046229 scopus 로고
    • Motor fluctuations in levodopa treated parkinsonian rats: Relation to lesion extent and treatment duration
    • Papa S.M., Eengber T.M., Kask A.M., ChaseE T.N. Motor fluctuations in levodopa treated parkinsonian rats relation to lesion extent and treatment duration. Brain Res. 662:1994;69-74.
    • (1994) Brain Res. , vol.662 , pp. 69-74
    • Papa, S.M.1    Eengber, T.M.2    Kask, A.M.3    Chasee, T.N.4
  • 51
    • 0034935182 scopus 로고    scopus 로고
    • L-Dopa induces dyskinesia in normal monkeys: Behavioural and pharmacokinetic observations
    • Pearce R.K., Heikkila M., Linden I.B., Jenner P. L-Dopa induces dyskinesia in normal monkeys behavioural and pharmacokinetic observations. Psychopharmacology (Berlin). 156:2001;402-409.
    • (2001) Psychopharmacology (Berlin) , vol.156 , pp. 402-409
    • Pearce, R.K.1    Heikkila, M.2    Linden, I.B.3    Jenner, P.4
  • 52
    • 0023787423 scopus 로고
    • Dystonia in Parkinson's disease: Clinical and pharmacological features
    • Poewe W.H., Lees A.J., Stern G.M. Dystonia in Parkinson's disease clinical and pharmacological features. Ann. Neurol. 23:1988;73-78.
    • (1988) Ann. Neurol. , vol.23 , pp. 73-78
    • Poewe, W.H.1    Lees, A.J.2    Stern, G.M.3
  • 53
    • 0019151790 scopus 로고
    • Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization or tolerance
    • Post R.M. Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life. Sci. 26:1980;1275-1282.
    • (1980) Life. Sci. , vol.26 , pp. 1275-1282
    • Post, R.M.1
  • 54
    • 0028126712 scopus 로고
    • Regulation by DZ dopamine receptors of in vivo dopamaine synthesis in striata of rats and mice with experimental parkinsonism
    • Richard M.G., Bennett J.P. Regulation by DZ dopamine receptors of in vivo dopamaine synthesis in striata of rats and mice with experimental parkinsonism. Exp. Neurol. 129:1994;57-63.
    • (1994) Exp. Neurol. , vol.129 , pp. 57-63
    • Richard, M.G.1    Bennett, J.P.2
  • 56
    • 0036723589 scopus 로고    scopus 로고
    • Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease
    • Stocchi F., Ruggieri S., Vacca L., Olanow C.W. Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease. Brain. 125:2002;2058-2066.
    • (2002) Brain , vol.125 , pp. 2058-2066
    • Stocchi, F.1    Ruggieri, S.2    Vacca, L.3    Olanow, C.W.4
  • 57
    • 0014954919 scopus 로고
    • DOPA effects on motility in mice: Potentiation by MK 485 and dexchlorpheniramine
    • Stromberg U. DOPA effects on motility in mice potentiation by MK 485 and dexchlorpheniramine. Psychopharmacology. 18:1970;58-67.
    • (1970) Psychopharmacology , vol.18 , pp. 58-67
    • Stromberg, U.1
  • 59
    • 0030182863 scopus 로고    scopus 로고
    • Dose-related effects of continuous levodopa infusion in rats with unilateral lesions of the substantia nigra
    • Trugman J.M., Hubbard C.A., Bennett J.P. Dose-related effects of continuous levodopa infusion in rats with unilateral lesions of the substantia nigra. Brain Res. 725:1996;177-183.
    • (1996) Brain Res. , vol.725 , pp. 177-183
    • Trugman, J.M.1    Hubbard, C.A.2    Bennett, J.P.3
  • 61
    • 0023730012 scopus 로고
    • Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage
    • Zhang W.Q., Tilson H.A., Nanry K.P., Hudson P.M., Hong J.S., Stachowiak M.K. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Brain Res. 461:1988;335-342.
    • (1988) Brain Res. , vol.461 , pp. 335-342
    • Zhang, W.Q.1    Tilson, H.A.2    Nanry, K.P.3    Hudson, P.M.4    Hong, J.S.5    Stachowiak, M.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.